SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 91 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 2.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $19,000 | -5.0% | 72,202 | -13.4% | 0.00% | – |
| Q1 2016 | $20,000 | -69.7% | 83,359 | -55.5% | 0.00% | -100.0% |
| Q4 2015 | $66,000 | -84.2% | 187,400 | -21.8% | 0.00% | -83.3% |
| Q3 2015 | $417,000 | -23.1% | 239,700 | -1.3% | 0.01% | -25.0% |
| Q2 2015 | $542,000 | +138.8% | 242,961 | +107.8% | 0.01% | +100.0% |
| Q1 2015 | $227,000 | +99.1% | 116,935 | +172.5% | 0.00% | +100.0% |
| Q4 2014 | $114,000 | -57.5% | 42,919 | -51.8% | 0.00% | -50.0% |
| Q3 2014 | $268,000 | +77.5% | 89,061 | +154.4% | 0.00% | +33.3% |
| Q1 2014 | $151,000 | -74.6% | 35,006 | -69.2% | 0.00% | -66.7% |
| Q4 2013 | $595,000 | +1252.3% | 113,618 | +1189.2% | 0.01% | +800.0% |
| Q2 2013 | $44,000 | – | 8,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |